Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Mar 24, 2026
Redmile Group's decision to offload $70.10 million in Zymeworks shares raises eyebrows amid the biotech firm's stock surge. Could this shift signal a strategic pivot in the biotech investing landscape?